Neuropsychological and behavioral aspects of transplants in Parkinson’s disease and Huntington’s disease

Brain and Cognition

Volumn 42, Issue 2, 2000, Pages 294-306

  Diederich, Nico J ^a,b   Goetz, Christopher G ^b  

^a Department of Neurology   (United Kingdom)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

fetal transplants; Huntington s disease; Parkinson s disease; xenotransplants

Indexed keywords

CELL TRANSPLANTATION; COGNITIVE DEFECT; DOPAMINERGIC NERVE CELL; EMOTIONALITY; FETUS CELL; HUMAN; HUNTINGTON CHOREA; INTELLECT; MOTOR DYSFUNCTION; NEUROPSYCHOLOGY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; XENOTRANSPLANTATION;

EID: 0034110779     PISSN: 02782626     EISSN: None     Source Type: Journal    
DOI: 10.1006/brcg.1999.1105     Document Type: Article

References (50)

1. Ali-Cherif A., Royere M. I., Gosset A., Poncet M., Salamon G., Khalil R. Troubles du comportement et de l'activité mentale après intoxication oxycarbonée. Revue neurologique. 140:1984;401-405.
2. Bakay R. A. E., Allen G. S., Apuzzo M., Bullard D. E., Ojemann G. A., Oldfield E. H., Penn R., Purvis J. T., Tindall G. T. Preliminary report on adrenal medullary grafting from the Amercian Association of Neurological Surgeons graft project. Dunnet S. B., Richards S. J. Neural transplantation from molecular basis to clinical applications. 1990;Elsevier, Amsterdam.
3. Bowen P., Kamienny R. S., Burns M. M., Yahr M. D. Parkinsonism: Effects of levodopa treatment on concept formation. Neurology. 25:1975;701-704.
4. Butters N., Salmon D. P., Heindel W., Granholm E. Episodic, semantic, and procedural memory: Some comparisons of Alzheimer and Huntington disease patients. Terry R. D. Aging and the brain. 1988;63-87 Raven Press, New York.
5. Celesia G. G., Barr A. N. Psychosis and other psychiatric manifestations of levodopa therapy. Archives of Neurology. 23:1970;193-200.
6. Cummings J. L. The dementias of Parkinson's disease: Prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. European Neurology. 28:1988;15-23.
7. Defer G. L., Geny C., Ricolfi F., Fenelon G., Monfort J. C., Remy P., Villafane G., Jeny R., Samson Y., Keravel Y., Gaston A., Degos J. D., Peschanski M., Cesaro P., Nguyen J. P. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain. 119:1996;41-50.
8. Delis D. C., Massman P. J. The effects of dopamine fluctuation on cognition and affect. Huber S. J., Cummings J. L. Parkinson's disease: Neurobehavioral aspects. 1992;Oxford Univ. Press, New York.
9. Desfontaines B., Pillon B., Deweer B., Dubois B., Laplane D. The mental and cognitive syndrome of patients with focal lesions of basal ganglia. Preliminary results. Ohye C., Kimura M., McKenzie J. S. The basal ganglia V. 1996;455-458 Plenum, New York.
10. Downes J. J., Roberts A. C., Sahakian B. J., Evenden J. L., Morris R. G., Robbins T. W. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction. Neuropsychologia. 27:1989;1329-1343.
11. Dubois B., Desfontaines B., Deweer B., Malapani C., Pillon B. Cognitive and behavioral changes in patients with focal lesions of the basal ganglia. Weiner W. J., Lang A. E. Behavioral neurology of movement disorders: Advances in neurology. 1995;29-41 Raven Press, New York.
12. Freed C. R., Breeze R. E., Rosenberg N. L., Schneck S. A., Kriek E., Qi J., Lone T., Zhang Y., Snyder J. A., Wells T. H., Olson Ramig L., Thompson L., Mazziotta J. C., Huang S. C., Grafton S. T., Brooks D., Sawle G., Schroter G., Ansari A. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. New England Journal of Medicine. 327:1992;1549-1555.
13. Freeman T. B., Olanow C. W., Hauser R. A., Nauert G. M., Smith D. A., Borlongan C. V., Sanberg P. R., Holt D. A., Kordower J. H., Vingerhoets F. J. G., Snow B. J., Calne D., Gauger L. L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Annals of Neurology. 38:1995;379-388.
14. Goetz C. G. Fetal tissue transplants. Fahn S. Innovative surgical treatment of movement disorders. 1998;73-84 Am. Acad. of Neurol. Minneapolis.
15. Goetz C. G., Diederich N. J. Neural transplants in Parkinson's disease. Koller W. C. Handbook of Parkinson's disease. 1992;545-567 Dekker, New York.
16. Goetz C. G., Stebbins G. T., Klawans H. L., Koller W. C., Grossman R. G., Bakay R. A. E., Penn R. D. The United Parkinson Foundation Neural Transplant Registry. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1-year follow-up. Neurology. 41:1991;1719-1722.
17. Goetz C. G., Pappert E. J., Blasucci L. M., Stebbins G. T., Ling Z. D., Nora M. V., Carvey P. M. Intravenous levodopa in hallucinating Parkinson's disease patients: High dose challenge does not precipitate hallucinations. Neurology. 50:1998;515-517.
18. Hallett, M., Litven, I., The task force on surgery for Parkinson's disease, 1999. Evaluation of surgery for Parkinson's disease: A report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology, 531910 -1921.
19. Henderson B. T., Clough C. G., Hughes R. C., Hitchcock E. R., Kenny B. G. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Archives of Neurology. 48:1991;822-827.
20. Henik A., Singh J., Beckley D. J., Rafal R. D. Disinhibition of automatic word reading in Parkinson's disease. Cortex. 29:1993;589-599.
21. Hitchcock E. R., Kenny B. G., Clough C. G., Hughes R. C., Henderson B. T. H., Detta A. Stereotactic implantation of foetal mesencephalon (STIM): The UK experience. Dunnett S. B., Richards S.-J. Progress in brain research. 1990;723-728 Elsevier, Amsterdam.
22. Kordower J. H., Goetz C. G., Freeman T. B. Dopaminergic transplants in patients with Parkinson's disease: Neuroanatomical correlates of clinical recovery. Experimental Neurology. 144:1997;41-46.
23. Kulkarni J., Horne M., Butler E., Keks N., Copolov D. Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease. Society of Biological Psychiatry. 31:1992;1225-1227.
24. Kurth M. C., Kopyov O. V., Jacques D. B., Caviness J. N., Duma M., Eagle S., Lieberman N. Safety of fetal tissue transplantation for Huntington's disease. Neurology. 48:1997;139.
25. Laplane D., Baulac M., Wildocher D., Dubois B. Pure psychic akinesia with bilateral lesion of the basal ganglia. Journal of Neurology, Neurosurgery and Psychiatry. 47:1984;377-385.
26. Lepore F. E. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology. 40:1990;444-447.
27. Leroy A., Michelet D., Mahieux F., Geny C., Defer G., Monfort J.-C., Degos J.-D., N'Guyen J.-P., Peschanski M., Cesaro P. Examen neuropsychologique de 5 patients Parkinsoniens avant et après greffe neuronale. Revue Neurologique. 152:1996;158-164.
28. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Lenders K. L., Sawle G., Rothwell B., Marsden C. D., Björklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577.
29. Lindvall O., Sawle G., Widner H., Rothwell J. C., Björklund A., Brooks D., Brundin P., Frackowiak R., Marsden C. D., Odin P., Rehncrona S. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Annals of Neurology. 35:1994;172-180.
30. Loápez-Lozano J. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: Five years follow-up in 10 patients. J., Bravo G., Brera B., Millan I., Dargallo J., Salmean J., Uria J., Insausti J. Clinica Puerta de Hierro Neural Transplantation Group. Journal of Neurosurgery. 86:1997;931-942.
31. Madrazo I., Franco-Bourland R., Ostrosky-Solis F., Aguilera M., Cuevas C., Zamorano C., Morelos A., Magallon E., Guizar-Sahagun G. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects. Archives of Neurology. 47:1990;1281-1285.
32. Madrazo I., Franco-Bourland R. E., Castrejon H., Cuevas C., Ostrosky-Solis F. Fetal striatal homotransplantation for Huntington's disease: First two case reports. Neurological Research. 17:1995;312-315.
33. Mendez M. F., Adams N. L., Lewandowski S. K. Neurobehavioral changes associated with caudate lesions. Neurology. 39:1989;349-354.
34. Menza M. A., Golbe L. I. Hypomania in a patient receiving deprenyl (selegiline) after adrenal-striatal implantation for Parkinson's disease. Clinical Neuropharmacology. 11:1988;549-551.
35. Olanow C. W., Kordower J. H., Freeman T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends in Neuroscience. 19:1996;102-109.
36. Ostrosky-Solis F., Quintanar L., Madrazo I., Drucker-Colin R., Franco-Bourland R. F., Leon-Meza V. Neuropsychological effects of brain autograft of adrenal medullary tissue for the treatment of Parkinson's disease. Neurology. 38:1988;1442-1450.
37. Peschanski M., Defer G., N'Guyen J. P., Ricolfi F., Monfort J. C., Remy P., Geny C., Samson Y., Hantraye P., Jeny R., Gaston A., Kéravel Y., Degos J. D., Cesaro P. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain. 117:1994;487-499.
38. Philpott L. M., Kopyov O. V., Lee A. J., Jacques S., Duma C. M., Caine S., Yang M., Eagle K. S. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplantation. 6:1997;203-212.
39. Pillon B., Dubois B., Cusimano G., Bonnet A. M., Lhermitte F., Agiol Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? Journal of Neurology, Neurosurgery and Psychiatry. 52:1989;201-206.
40. Price L. H., Spencer D. D., Marek K. L., Robbins R. J., Leranth C., Farhi A., Naftolin F., Roth R. H., Bunney B. S., Hoffer P. B., Makuch R., Redmond D. E. Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease. Society of Biological Psychiatry. 38:1995;498-505.
41. Sanchez-Ramos J. R., Ortoll R., Paulson G. W. Visual hallucinations associated with Parkinson's disease. Archives of Neurology. 53:1996;1265-1268.
42. Sass K. J., Buchanan C. P., Westerveld M., Marek K. L., Farhi A., Robbins R. J., Naftolin F., Vollmer T. L., Leranth C., Roth R. H., Price L. H., Bunney B. S., Elsworth J. D., Hoffer P. B., Redmond E., Spencer D. D. General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's disease. Archives of Neurology. 52:1995;680-686.
43. Shannon K. M., Goetz C. G. Transplantation of adrenal medullary tissue to brain in Parkinson's disease. Koller W. S., Paulson G. Therapy of Parkinson's disease. 1994;423-434 Dekker, New York.
44. Spencer D. D., Robbins R. J., Naftolin F., Marek K. L., Vollmer T., Leranth C., Roth R. H., Price L. H., Gjedde A., Bunney B. S., Sass K. J., Elsworth J. D., Kier E. L., Makuch R., Hoffer P. B., Redmond D. E. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. New England Journal of Medicine. 327:1992;1541-1548.
45. Stebbins G. T., Tanner C. M. Behavioral effects of intra striatal adrenal medullary surgery in Parkinson's disease. Huber S. J., Cummings J. L. Parkinson's disease: Neurobehavioral aspects. 1992;328-345 Oxford Univ. Press, New York.
46. Stern Y., Langston W. Intellectual changes in patients with MPTP-induced parkinsonism. Neurology. 35:1985;1506-1509.
47. Tanner C. M., Goetz C. G., Gilley D. W., Shannon K. M., Stebbins G. T., Klawans H. L., Wilson R. S., Penn R. M. Behavioral aspects of intra striatal adrenal medulla transplant surgery in Parkinson's disease. Neurology. 38:1998;143-144.
48. Taylor A. E., Saint-Cyr J. A., Lang A. E. Parkinson's disease: Cognitive changes in relation to treatment response. Brain. 110:1987;35-51.
49. Thompson L. L., Cullum C. M., O'Neill S., Freed C. R. Effects of fetal cell transplantation on cognitive and psychological functioning in Parkinson's disease. Archives of Clinical Neuropsychology. 12:1997;46.
50. Wenning G. K., Odin P., Morrish P., Rehncrona S., Widner P., Brundin P., Rothwell J. C., Brown R., Gustavi B., Hagell P., Jahanshahi M., Sawle G., Björklund A., Brooks D. J., Marsden C. D., Quinn N. P., Lindvall O. Short- and long-term survival and function of unilateral intra striatal dopaminergic grafts in Parkinson's disease. Annals of Neurology. 42:1997;95-107.